Researchers at Center for Clinical and Translational Science Release New Data on Health Insurance (163 Private or Public Health Insurance and Infant Outcomes in the United States): Health Insurance

2023 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Hospital & Nursing Home Daily -- New study results on health insurance have been published. According to news reporting from the Center for Clinical and Translational Science by NewsRx journalists, research stated, “OBJECTIVES/GOALS: Health insurance status is associated with differences in access to healthcare and health outcomes. The objective of this study was to test the hypothesis that among infants born in the United States, maternal private insurance compared with public Medicaid insurance would be associated with a lower infant mortality rate (IMR). METHODS/STUDY POPULATION: This ecological study used data from the Center for Disease Control and Prevention (CDC) WONDER expanded linked birth and infant death records database 2017-2018.”

The news reporters obtained a quote from the research from Center for Clinical and Translational Science: “We included hospital-born infants from 20 to 42 weeks of gestational age (wga) if the mother had either private or Medicaid insurance. We excluded infants with congenital anomalies and infants who died due to congenital anomalies. We used negative-binomial regression adjusted for race, sex, multiple birth, and any maternal pregnancy risk factors (as defined by the CDC) to determine the difference in IMR between private and Medicaid insurance. Chi-square or Fishers exact test was used to compare differences in categorical variables between groups. RESULTS/ANTICIPATED We included 6,901,328 infants; 53.6% had private insurance and 46.4% were insured by Medicaid. Privately insured infants had a lower IMR compared with Medicaid insured infants (2.84/1000 vs. 5.32/1000; adjusted relative risk (aRR) 0.71; 95% confidence intervals (CI) 0.62 to 0.81; p<.0001). The privately insured had higher rates of 1st trimester prenatal care compared to those with Medicaid (85.6% vs. 66.6%; p<.00001). Rates of infant morbidity and maternal morbidity (per CDC definitions) were lower among the privately insured compared to those with Medicaid (both p<.00001). The privately insured had lower rates of preterm (9.1% vs. 11.0%), extremely preterm (0.5% vs. 0.7%), low birth weight (7.1% vs. 9.6%), and extremely low birth weight (0.5% vs. 0.7%) births compared to those with Medicaid (all p<0.001). DISCUSSION/SIGNIFICANCE: Private insurance is associated with a lower IMR compared to Medicaid insurance.”

According to the news editors, the research concluded: “Privately insured pregnancies also have higher rates of early prenatal care, less morbidity, and less preterm and low birth weight births. There may be opportunities to improve access to care and pregnancy outcomes among Medicaid insured pregnancies in the United States.”

For more information on this research see: 163 Private or Public Health Insurance and Infant Outcomes in the United States. Journal of Clinical and Translational Science, 2022,6():18-18. (Journal of Clinical and Translational Science - https://www.cambridge.org/core/journals/journal-of-clinical-and-translational-). The publisher for Journal of Clinical and Translational Science is Cambridge University Press.

A free version of this journal article is available at https://doi.org/10.1017/cts.2022.71.

Our news journalists report that more information may be obtained by contacting Desalyn Louise Johnson, Center for Clinical and Translational Science (CCTS).

(Our reports deliver fact-based news of research and discoveries from around the world.)